News About Laboratory Services

 

Diagnostyka partners with symptom checker

CEE's largest lab company Diagnostyka has partnered with digital symptom checker Infermedica in a bid to capture patient flows and leverage the data it collects.

Is Citilab in decline?

Russian lab group Citilab, once the second largest player on the market, has apparently seen a drop in revenue over the past three years. HBI investigates.

Major shake up of UK lab market expected by 2021

HBI understands a quarter of the UK's pathology outsourcing contracts - and at least a half of its revenue - could switch hands over the next two years, which could potentially see a major shake-up of the market share among the top players.

Lifestyle genetic platforms under fire

Insurers and big occupational healthcare providers are sceptical about a new generation of lifestyle genetic testing linked to apps which are designed to enable individuals to achieve higher levels of wellness. But they are starting to deploy more specific tests that diagnose rare diseases. We talk to major operators and insurers about how they see the genetic test market.

Unilabs finalises high multiple acquisition

Pan-European Switzerland-based lab group Unilabs has finalised the acquisition of a smaller French competitor, Biopath, for what we think is the highest multiple the consolidating French lab market has seen so far. Healthcare Europa names the price. 

The key to B2C lab testing in Europe

A big lab group appears to have cracked the key to making money from B2C tests and is already selling hundreds of thousands such tests a year online. That would be quite an achievement. We name names.

Quest Diagnostics changes strategy in emerging markets

Last week Healthcare Nova reported that US-based lab company Quest Diagnostics had sold its Indian medical diagnostics arm to Strand Life Sciences. We also reported that Quest has set up an international alliance of lab companies based in Brazil, Saudi Arabia, Korea, Hong Kong and Australia. Are the two moves connected? We speak to Quest's MD of global markets, Mark Machulcz to find out more about the group's change of strategy.

Cerba buys again in France

European lab group Cerba has continued to hoover up French labs, acquiring smaller rival Accolab from private equity firm LFPI Gestion. We name the price. 

Medicover buys new lab in Ukraine

Medicover's lab arm Synevo has acquired the Ukrainian diagnostics operations of Russian lab group Invitro for €6m, further sealing its dominant position.

Find Us